A climber became the first person to master a climbing route on a flying glider. Missouri mom shot, stabbed 16-year-old son to death while he slept: Police Israeli military arrests Greta Thunberg, ...

The built-in cup holder is perfect for your morning cup of joe. TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. From ...

One shopper said that it "looks like it will last for years." TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission.

Expert DIYer April Wilkerson builds a comfortable wooden bench glider for relaxing outdoors. Hegseth orders rare, urgent meeting of hundreds of generals, admirals ‘Unforced errors’ weigh on GOP’s ...

Pets in Grow a Garden increase crop growth and garden productivity by giving bonus experience, mutating crops, reducing cooldowns, and more. Sugar Glider is a Mythical-rarity Pet added by the Fall ...

Calls for a specific squawk code to be designated for gliders have emerged after a USAF KC-135 Stratotanker came within 15 metres of colliding with a glider over Eastern England. On Apr. 8, 2025, a KC ...

Jake Scrace has performed the highest ever kite surfing "tow up" in history, according to Guinness World Records A kite surfer from West Sussex has set a new world record for the highest "tow up" ...

Gilead Sciences' Kite Pharma has cut off a collaboration with Shoreline Biosciences, ending a research collaboration on off-the-shelf cell therapies that was valued at more than $2.3 billion. The deal ...

Santa Monica-based Kite, a Gilead company, agreed to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR therapeutics, for $350 million. “In vivo therapy is ...

Oh, go fly a kite, Milwaukee. No, seriously, go fly a kite this weekend! Gift of Wings will host the annual Frank Mots International Kite Festival at Veterans Park this weekend. The event runs ...

Kite Pharma's acquisition of Interius BioTherapeutics aims to integrate in vivo CAR T-cell therapy with Kite's expertise, enhancing patient treatment options. The $350 million acquisition is expected ...